Literature DB >> 30760107

Ligasure impact might reduce blood loss, complications, and re-operation occurrence after abdominoplasty in massive-weight-loss patients: A Comparative Study.

S Giordano1,2,3, R Kangas1,3, E Veräjänkorva1,3, I Koskivuo1,3.   

Abstract

BACKGROUND AND AIMS: The most effective dissection technique for raising the flap in abdominoplasty is still controversial, particularly in high-risk massive-weight-loss patients. LigaSure Impact™ vessel-sealing system (Medtronic, Dublin, Ireland) is an energy device commonly used among different surgical specialties to reduce morbidity and implement outcomes. The aim of this study was to investigate the effectiveness of LigaSure Impact in abdominoplasty compared with the conventional techniques, diathermia.
MATERIAL AND METHODS: Patients underwent primary abdominoplasty after massive weight loss at a single center from 1 January 2008 to 31 May 2015 and were retrospectively reviewed. A total of 94 patients eligible for the study were divided into two groups on basis of the dissection technique: LigaSure Impact group (29 patients) and the conventional technique group (65 patients). Total intraoperative blood loss was the primary endpoint. Duration of the operation, perioperative complications and re-operation were recorded as secondary endpoints.
RESULTS: Baseline characteristics were well balanced between the groups. Significant differences were found in intraoperative blood loss favoring LigaSure Impact group (259.6 ± 198.8 mL vs 377.9 ± 190.0 mL, p = 0.004) and blood transfusion rates (13.8% vs 35.4%, p = 0.047). In contrast, operative time was significantly longer in LigaSure Impact group (168.6 ± 121.2 vs 179.7 ± 57.6 min, p = 0.005), while a tendency to shorter hospital stay was found in LigaSure Impact group (3.6 ± 1.1 days vs 4.6 ± 3.2 days, p = 0.081). Overall complications occurrence, Clavien-Dindo grade II (24.1% vs 55.4%) and grade III (13.8% vs 30.8%) complications were significantly lower in LigaSure Impact group (respectively, p = 0.005, p = 0.007, p = 0.016). Late (>30 days) re-operation rate was significantly lower in the LigaSure Impact group (6.9% vs 27.70%, p = 0.0028). Specific wound complications showed no significant difference.
CONCLUSION: LigaSure Impact vessel-sealing system may be beneficial in improving abdominoplasty outcomes in massive-weight-loss patients because it might reduce blood loss, need for transfusions, complications, and re-operations.

Entities:  

Keywords:  Clavien–Dindo classification; LigaSure Impact; abdominoplasty; bipolar electrothermal vessel sealer; blood loss; blood transfusion; body-contouring surgery; complications

Mesh:

Year:  2019        PMID: 30760107     DOI: 10.1177/1457496919828237

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  5 in total

1.  LigaSure Impact™ reduces complications after abdominoplasty in weight loss patients.

Authors:  Sonia Radunz; Haider Salem; Philipp Houben; Andreas Pascher; Martin Büsing; Markus Utech
Journal:  Langenbecks Arch Surg       Date:  2021-08-31       Impact factor: 2.895

2.  Detection of the Lateral Thermal Spread during Bipolar Vessel Sealing in an Ex Vivo Model-Preliminary Results.

Authors:  Andreas Kirschbaum; Jan Jonas; Thomas M Surowiec; Anika Pehl; Nikolas Mirow
Journal:  Diagnostics (Basel)       Date:  2022-05-12

Review 3.  Abdominoplasty: Pitfalls and Prospects.

Authors:  Nayef A Louri; Hamad M Ammar; Fatema Abduljabbar Abdulkariml; Turki Abdulla Sanad Ahmed Eid Alkhaldi; Rashed Noaman AlHasan
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

4.  LigaSure versus monopolar cautery for recipient hepatectomy in liver transplantation: a propensity score-matched analysis.

Authors:  Jeong-Moo Lee; Kwangpyo Hong; Eui Soo Han; Sanggyun Suh; Suyoung Hong; Suk Kyun Hong; YoungRok Choi; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Ann Transl Med       Date:  2021-07

5.  Use of energy device in general surgical operations: impact on peri-operative outcomes.

Authors:  Olalekan Olasehinde; Afolabi Owojuyigbe; Adekunle Adeyemo; Arinzechukwu Mosanya; Olurotimi Aaron; Funmilola Wuraola; Temitope Owoniya; Temilola Owojuyigbe; Olusegun Alatise; Adewale Adisa
Journal:  BMC Surg       Date:  2022-03-09       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.